© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
A checkpoint inhibitor combination and an antibody-drug conjugate may offer new treatment options.
The report highlights how cancer research is extending and improving lives and includes a special feature on COVID-19 and cancer challenges.
Through her sculptures, Shelley Kerr describes the battle, journey and gratitude of living with stage IV bladder cancer.
June is Cancer Immunotherapy Month
Cancer-fighting T cells led to complete or partial tumor remission in at least 25% of lung cancer patients.
Edited T cells survive and thrive in three patients in the first U.S. trial using this approach.
Customized treatments demonstrate good response rates for mantle cell lymphoma and chronic lymphocytic leukemia.
Space travel and chemotherapy affect the body similarly, and yet only astronauts undergo physical conditioning to help them stay strong.
A look back at some of the major news stories we covered this year.
The new therapies include immune checkpoint inhibitors; therapeutic vaccines; CAR T-cell therapies; and “conjugate” drugs.
New tech enables deep dive into mysterious results, sets stage for future improvements.
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
